Abstract
In late December 2019, an outbreak of the novel coronavirus disease (COVID-19) was started in Wuhan, China, and quickly reached the other countries of the world. In comparison with the other members of coronaviruses family such as SARS-CoV and MERS-CoV, COVID-19 appears to have a lower fatality rate (virulence). However, the high transmission rate of this virus, as well as the lack of vaccines and certain pharmaceutical treatments for COVID-19 have posed serious challenges to the control of the disease spread.
License
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Article Type: Letter to Editor
ELECTRON J GEN MED, Volume 17, Issue 4, August 2020, Article No: em203
https://doi.org/10.29333/ejgm/7856
Publication date: 27 Mar 2020
Article Views: 7466
Article Downloads: 11739
Open Access Disclosures References How to cite this article